Dechra Pharmaceuticals Investor Relations Material
Latest events
H1 2023
Dechra Pharmaceuticals
H2 2023
12 Oct, 2023
Trading Update
22 May, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Dechra Pharmaceuticals plc
Access all reports
Dechra Pharmaceuticals plc is a global veterinary pharmaceuticals company specializing in the development, manufacture, and distribution of products for animal health. The company provides a broad range of pharmaceuticals, including treatments for companion animals and livestock, as well as veterinary-specific diet products. Its offerings cover therapeutic areas such as endocrinology, dermatology, pain management, and anti-infectives. The company is headquartered in Northwich, United Kingdom, and its shares are listed on the LSE (London Stock Exchange).
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
DPH
Country
🇬🇧 United Kingdom